AHGIF (Alternate Health) Shares Buyback Ratio %: -44.53 (As of Sep. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Alternate Health Shares Buyback Ratio %?

Alternate Health AHGIF -99.00% Shares Buyback Ratio % is -44.53 as of Sep. 17, 2026.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Alternate Health's current shares buyback ratio was -44.53%.

Alternate Health Shares Buyback Ratio % Related Terms

Alternate Health Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Alternate Health's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alternate Health Shares Buyback Ratio % Chart

Alternate Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18
Shares Buyback Ratio %
0.00 36.54 -59.90 -28.49

Alternate Health Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Mar19 Jun19 Sep19
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -2.19 -25.58 -10.68 -3.99

Alternate Health Shares Buyback Ratio % Calculation

Alternate Health's Shares Buyback Ratio for the fiscal year that ended in Dec. 2018 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2017 ) - Shares Outstanding (EOP) (A: Dec. 2018 )) / Shares Outstanding (EOP) (A: Dec. 2017 )
=(52.631278 - 67.627096) / 52.631278
=-28.49%

Alternate Health's Shares Buyback Ratio for the quarter that ended in Sep. 2019 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2019 ) - Shares Outstanding (EOP) (A: Sep. 2019 )) / Shares Outstanding (EOP) (A: Jun. 2019 )
=(74.897095 - 77.884996) / 74.897095
=-3.99%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -44.53 mean?
Alternate Health (AHGIF) has a Shares Buyback Ratio % of -44.53 as of Sep. 17, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Alternate Health and its competitors.
Is Alternate Health's Shares Buyback Ratio % too high?
Alternate Health's current Shares Buyback Ratio % is -44.53.
How does Alternate Health's Shares Buyback Ratio % compare to VEEV and CERN?
Alternate Health's Shares Buyback Ratio % of -44.53 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Healthcare Providers & Services company?
A good Shares Buyback Ratio % depends on the Healthcare Providers & Services industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Alternate Health and its competitors. Alternate Health's current Shares Buyback Ratio % is -44.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alternate Health stock overvalued right now?
Alternate Health (AHGIF) has a current Shares Buyback Ratio % of -44.53. The current Shares Buyback Ratio % is -44.53. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Alternate Health (AHGIF), the current Shares Buyback Ratio % is -44.53 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alternate Health Business Description

Address 7373 Broadway Street, Suite 307, San Antonio, TX, USA, 78209
Alternate Health Corp is a healthcare company. It uses expertise in technology and data analytics to revolutionize patient care and research in the emerging medical cannabis industry. It offers practice management and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry.